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The reactivity of the stress system may change during the life course. In many—but not
all—humans the stress reactivity decreases, once the individual is chronically exposed
to a stressful and unsafe environment (e.g., poverty, work with high demands, unhappy
martial relationship). Such an adaptation is referred to as habituation. Stress habituation
allows alleviating the burden of chronic stress, particularly cardiovascular morbidity and
mortality. Interestingly, two recent experiments demonstrated low stress reactivity during
a mental or psychosocial challenge in subjects with a high body mass. In this focused
review we attempt to integrate these experimental findings in a larger context. Are these
data compatible with data sets showing a prolonged life expectancy in corpulent people?
From the perspective of neuroenergetics, we here raise the question whether “obesity”
is unhealthy at all. Is the corpulent phenotype possibly the result of “adaptive phenotypic
plasticity” allowing optimized survival in stressful environments?
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INTRODUCTION
“Obesity” is commonly regarded as a disease.
The term is derived from the Latin obesus
“having eaten until fat” (from ob- “away, com-
pletely” + esus past participle of edere “eat”).
As this word origin suggests, “obesity” is widely
considered as a controllable condition, and its
cause is often attributed to a lack of willpower
or discipline (Sikorski et al., 2012). Recent clin-
ical data, however, clearly contradict the prej-
udice of weak will, since children and adults
with high body mass index (BMI) display a
stronger cognitive control over eating behavior
than all others (Timko and Perone, 2005; de
Lauzon-Guillain et al., 2006; Snoek et al., 2008;
Gallant et al., 2010). Moreover, with upcom-
ing new epidemiological data the question
arises whether a high BMI is unhealthy at all
(Flegal et al., 2013).
The nephrologists were the first who
reported that patients on dialysis treatment
had better survival chances when they had
a higher BMI (Kopple et al., 1999). This
phenomenon—often referred to as the “obesity
paradox”, has also been observed in other
diseases like myocardial infarction, stroke,
pulmonary disease, sepsis, and type 2 diabetes
mellitus (Buettner et al., 2007; Hallin et al.,
2007; Vemmos et al., 2011; Carnethon et al.,
2012). In the first place, these data sets had been
classified as special cases being only relevant in
intensive care units. However, recent studies in
general populations from Mauritius, Denmark,
and Great Britain showed that people with
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higher BMI (“overweight” and “obese”) liveThe Obesity Paradox
The term reflects the controversy which
arose from conflicting study results:
while some studies reported negative
associations between body mass and
mortality risk, others reported positive
associations between the two variables.
longer than those with lower BMI (“normal
weight”) (Berentzen et al., 2010; Cameron et al.,
2012; Hamer and Stamatakis, 2012). These
observations raised doubt about the common
assumption that obesity is a harmful disease. Is
it even possible that in a stressful environment a
“corpulent phenotype” develops which is more
stress tolerant and finally has better survival
chances?
Here we argue from a perspective of neuroen-
ergetics and we shall provide evidence support-
ing the notion that weight gain in humans is
an adaptive strategy allowing better survival in
stressful-unsafe environments.
THE SELFISH BRAIN
The brain occupies a special hierarchical posi-
tion in human energy metabolism (Peters et al.,
2004). Almost 100 years ago Marie Krieger pro-
vided first scientific evidence for the central
position of the brain in energy metabolism. She
reported that in the state of inanition all the
organs like the heart, the liver, and the kid-
ney lost approximately 40% of their mass, while
the brain mass hardly changed (less than 2%)
(Krieger, 1921). Using a mathematical logistic
approach, which is based on the principles
of “supply and demand” known from eco-
nomics, we could show that brain supply must
be regulated both by offer and demand (Peters
and Langemann, 2009). In order to show this,
we have designed a brain-supply-chain model
(Figure 1A). Because the brain has been demon-
strated to be both the principle consumer and
the principle controller in energy metabolism,
we have regarded it as the final consumer in this
model. Energy from the remote environment
A
C
B
FIGURE 1 | General supply chain of the human brain. (A) Overview: energy from the remote environment is
brought to the immediate environment, the body then takes it up, and from there a large part of it enters the brain.
(B) The push-pull principle: in a general supply chain, the flux of energy can principally be determined by the supplier
(previous step) or by the receiver (proximate step). The share of the flux, which is determined by the supplier, is
called the “push component” (blue arrows), the share, which is determined by the receiver, is called the “pull
component” (yellow arrows). (C) Conceptual diagram that shows key physiological mechanisms, which fulfill the
brain-pull function of cerebral insulin suppression (CIS): the flux of glucose is either directed to the brain or to muscle
and fat. If neuronal ATP concentrations fall, activation of neurons in the amygdala, in the ventromedial hypothalamus
(VMH), and in the paraventricular nucleus (PVN) occurs, which in turn activates the sympathetic nervous system and
the hypothalamus pituitary adrenal system (SNS and HPA). Both the SNS and the HPA system suppress insulin
release from pancreatic beta cells, thereby decreasing glucose transporter 4 (GLUT-4) mediated glucose uptake into
muscle and fat. In this way the brain limits glucose uptake in peripheral tissues and favors glucose transporter 1
(GLUT-1) mediated glucose uptake into the brain. Finally, the CIS-brain-pull system is hierarchically organized and
adaptive. The central glucocorticoid feedback plays a critical role in determining whether the CIS-brain-pull system
reacts in a high or low reactive manner. ACTH, Adrenocorticotropic hormone; E, epinephrine; NE, norepinephrine.
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is brought to the immediate environment, then
the body takes it up (into the blood stream),
and from there approximately 2/3 of the cir-
culating glucose enters in the brain. Supply
chains in industrial production processes dis-
play striking similarities to the glucose pathway
from the environment through the body toward
the brain. In the field of logistics such sup-
ply chains have been extensively studied. Over
the decades, a number of basic principles have
been formulated and elaborated (Slack et al.,
2004). The so-called “push”-principle operates
according to the following rule (Figure 1B):
the supplier delivers material and in so doing
determines the activity of a production step. In
contrast, the so-called “pull”-principle works in
the following manner: the material required for
a production step is provided only when the
receiver needs it (just-in-time). In comparison
with the “push”-principle the “pull”-principle
offers clear economic advantages; with the lat-
ter there are short set-up times and only small
(economically optimized) storage sites. Many
modern industrial branches have recognized
that pull components are particularly efficient.
While designing our brain-supply-chain model
we referred to the basic principles of general
supply chains. With the help of such a brain-
supply-chain model we could show that the
existence of an active cerebral-demandprocess is
indispensable for explaining the observed brain
mass preservation, which occurs under condi-
tions of food deprivation. The force with which
the brain actively demands energy from the
body is referred to as “brain-pull.”Brain-pull
The brain regulates energy homeostasis
via “brain-pull mechanisms,” which
function by demanding energy from
the body. Two classes of brain-pull
mechanisms have been detected so far:
first, allocative brain-pull mechanisms,
which activate the stress system to favor
energy allocation to the brain, and,
second, direct astrocytic brain-pull
mechanisms, which enhance glucose
transport through the blood–brain
barrier.
Cerebral insulin suppression (CIS)
With cerebral activation of the stress
systems, energy—particularly
glucose—is allocated to the brain. With
activation of the sympathetic nervous
system, insulin secretion from the beta
cells is suppressed and the
insulin-dependent glucose uptake into
body periphery becomes limited. As a
consequence of CIS, glucose is available
via insulin-independent transport
across the blood–brain barrier. In this
way, CIS can be interpreted as a
brain-pull mechanism.
First evidence for the existence of brain-
pull mechanisms came from the laboratory
studies of Luc Pellerin and Pierre Magistretti
(Magistretti et al., 1999). On the cell-to-cell
level, the researchers showed that neurons
actively demand energy from the blood via
astrocytes. On the systemic level, brain-pull
mechanisms have been discovered, which allow
allocation of energy from the body toward the
brain. One key brain-pull mechanism is referred
to as “cerebral insulin suppression” (CIS)
(Kubera et al., 2012). CIS operates in follow-
ing way (Figure 1C): both the medial amygdala
nucleus and the ventromedial hypothalamus
contain glucose-responsive neurons, which con-
trol the activity of the sympathetic nervous
system (SNS) and the hypothalamus-pituitary
adrenal axis (HPA) (Miki et al., 2001; Zhou
et al., 2010). The medial amygdala nucleus sends
heavy input to the ventromedial hypothala-
mus and thereby exerts control over its activity
(Petrovich et al., 2001). In the ventromedial
hypothalamus, ATP-sensitive potassium (KATP)
channels have been shown to monitor intra-
cellular ATP (Spanswick et al., 1997). If the
cerebral intracellular ATP concentrations fall,
ventromedial hypothalamus neurons depolar-
ize due to GABAergic disinhibition (Chan
et al., 2007). Via glutamatergic mechanisms
they activate the sympathoadrenal system (Tong
et al., 2007). Specific sympathetic efferences
project to pancreatic beta-cells and in so
doing inhibit insulin secretion (Ahren, 2000).
Ventromedial hypothalamus-controlled sympa-
thetic efferences also project to muscle and
fat tissue, where they inhibit insulin-dependent
glucose transport via GLUT 4 (Mulder et al.,
2005). Thus, the ventromedial hypothalamus
neurons are capable of limiting the flux of glu-
cose from the blood into the peripheral energy
stores (muscle and fat tissue). As a consequence,
glucose is now available via insulin-independent
GLUT1-transport across the blood-brain bar-
rier (Hasselbalch et al., 1999; Seaquist et al.,
2001). CIS can be interpreted as a brain-pull
mechanism that functions to demand energy
from the body. In this way, the brain is able to
adjust its energy supply to its varying energy
needs.
Cerebral energy demand mechanisms like
CIS are activated during psychosocial stress.
During acute stress episodes, vigilance increases;
the reaction time decreases, and alternative
behavioral strategies are searched for (explo-
ration). This stress-induced behavioral state of
hypervigilance requires extra energy (Madsen
et al., 1995; Hitze et al., 2010). By activating
brain-pull mechanisms the brain demands for
extra energy from the body and thereby cov-
ers such cerebral extra needs. The stress-induced
behavioral state allows high cerebral functioning
for problem solving—but this special functional
mode costs additional energy. In all, a high-
reactive stress system is required for entering a
highly functional cerebral mode during stress.
HABITUATION OF THE STRESS RESPONSE
The reactivity of the stress system may change
during the life course. Once exposed to a
stressful environment (e.g., poverty, unhappy
martial relationship, high demand at work,
loneliness), humans are known to react in two
distinct patterns (Kirschbaum et al., 1995):
type-A-individuals are characterized by their
maintenance of a high-reactive stress response
under conditions of permanent or repeated
stress. They do not show any signs of habitu-
ation. And they lose body weight (Figure 2A).
In contrast, type-B-individuals, who initially
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FIGURE 2 | The effect of stress on body weight and mortality risk. (A) The bifurcation of the life course: once an
individual is exposed to a stressful environment its body weight changes: in type-A-individuals the body mass index
(BMI) decreases, while in type-B the BMI increases. (B) The confounding factor “stress”: stress has been shown to
affect both the BMI and the mortality risk. Therefore, stress can be regarded as a confounding factor, which
definitely influences the BMI-mortality association.
responded to stress in a high-reactive manner,
decrease their stress response by time and in
this way they continue to respond to stress in
a low-reactive manner. They do exhibit signs of
habituation. And they gain weight (Figure 2A).
As estimated from data in a young study popu-
lation fromGreat Britain, 50% of the participat-
ing individuals can be considered as type A and
50% as type B (Oliver and Wardle, 1999).
Phenotypic plasticity
Phenotypic plasticity is an
environmentally based change in
phenotype. Fundamental to the way in
which organisms cope with
environmental variation, phenotypic
plasticity encompasses all types of
environmentally induced changes
(e.g., morphological, neuroendocrine,
behavioral) that may or may not be
permanent throughout an individual’s
lifespan.
Allostatic load
The concept of “allostatic load,” which
has been introduced by McEwen and
Stellar (1993), is based on the
hypothesis that there is a cumulative
physiological risk associated with
exposure to psychosocial stressors over
the life-course. Adaptation in the face
of stressful situations and stimuli
causes allostatic load and this, over
time, leads to diseases.
The molecular basis underlying the pro-
cess of stress habituation has recently been
identified. The endocannabinoid system in the
prefrontal cortex plays a key role in stress
habituation (Hill et al., 2010). If stressors
cannot be defended successfully in the long
run, then a learning process involving synaptic
plasticity (long-term potentiation; LTP) within
the prefrontal cortex allows suppressing the
potential amygdala response to the stressor
(Freund et al., 2003; Hill and Tasker, 2012).
The induction of LTP at synapses is facili-
tated by the endocannabinoid system (Carlson
et al., 2002). The synaptic changes during
stress habituation result in a damped response
of the SNS and the hypothalamus-pituitary-
adrenal axis (Kirschbaum et al., 1995). Whether
an individual exhibits a type-A- or a type-
B-stress response is determined by the char-
acteristics of the endocannabinoid systems.
These characteristics are essentially based on
genetic factors. Thus, the genetic predisposi-
tion determines whether signs of habituation are
present or absent when the individual is exposed
to chronic stress.
Evolutionary biology has extensively studied
adaptations to environmental changes. When
environments within the range of a species dif-
fer, it is unlikely that any single phenotype will
confer high fitness in all situations. In such a
case, a change in the phenotype (e.g., change
in the stress reactivity or interchange between
asexual and sexual reproduction) that depends
on the environment (phenotypic plasticity)
can provide increased environmental tolerance
(Via et al., 1995; Agrawal, 2001).
THE BENEFITS AND COSTS OF A
LOW-REACTIVE STRESS SYSTEM
In 1993 Bruce McEwen introduced the con-
cept of allostatic load into medicine (McEwen
and Stellar, 1993). Allostatic load refers to the
damaging effect of a chronically activated stress
response. It has been shown that chronically
stressed individuals do not only display high lev-
els of serum cortisol and weight loss, but are
also at high risk to die earlier, become infertile,
develop arteriosclerosis, arterial hypertension,
coronary heart disease, myocardial infarction,
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stroke, typical depression, muscle atrophy, and
osteoporosis. In principle, a high-reactive stress
system may be highly effective in defending
against stressors. But if removal of the stressor
or escape from it is impossible, then a perma-
nent high-reactive stress system turns out to be
detrimental.
Therefore, habituation of the stress response
is of benefit, if the stressor cannot be successfully
removed. Then, habituation reduces the dam-
aging effects of the allostatic load. Habituation
results in a maintained biological fitness once
the individual is set into a stressful-insecure
environment.
On the other hand, habituation of the stress
response is also costly. Once habituation occurs
in the stress system, the brain-pull function—
usually carried out by a high-reactive stress
system—is no longer effective. Then, the brain is
unable to demand for sufficient energy from the
body. There is, however, one alternative to pre-
serve cerebral energy homeostasis under these
adverse circumstances: the increase of inges-
tive behavior. If the food offer is abundant,
then individuals who have developed a low-
reactive stress system are able to procure their
brain by a compensatory increase in food intake.
However, this alternative strategy of the brain
has an unwanted side effect: weight gain. Using
the logistic model of the cerebral supply chain,
it has been proven analytically that the reactiv-
ity of the brain-pull function is strictly inverse
to the energy fill level of the body (body mass)
(Peters and Langemann, 2009). In other words:
a high-reactive stress system allows effectively
demanding energy from body stores; it guaran-
tees immediate adjustment of the brain’s energy
supply to its varying energy needs. In contrast,
a low-reactive stress system does not allow suf-
ficiently procuring energy from body stores; as
a compensatory strategy, the brain may switch
from brain-pull to body-pull (Figure 1A); in
The supply chain of the brain
With the central nervous system as the
final consumer—describes the energy
fluxes from the remote environment to
the near environment, through the
body and finally toward the brain. The
brain regulates energy homeostasis via
brain-pull mechanisms.
The body-pull
Functions to demand energy from the
near environment by initiating
ingestive behavior to replenish body
stores and blood glucose
concentrations. In this connection,
mechanisms driven by extracellular
cerebral glucose, which is closely related
to blood glucose, fulfill the function of
exerting ingestive body-pull.
this way, the brain’s needs are covered, but the
surplus of energy accumulates in the body—and
the result is weight gain. Thus, we may consider
weight gain as the cost, which has to be paid for
the adaptive benefits of stress habituation.
In summary, stress habituation can be
regarded as an adaptive and beneficial process,
which reduces the allostatic load under chronic
stress conditions; and it also is associated with
the costs of weight gain.
LOW-REACTIVE STRESS SYSTEM IN THE
CORPULENT PHENOTYPE
Long-term observational studies have demon-
strated that a low-reactivity of the stress
system—either measured by the adrenalin
response during a mental stress test or by heart
rate variability—is a strong predictor of weight
gain (Carroll et al., 2008; Flaa et al., 2008).
Twenty-five years ago, it has already been recog-
nized that body fat is related to a low-reactivity
of the autonomic nervous system (Peterson
et al., 1988). The higher the body fat was, the
smaller the cardiac responses to stress were, the
lower the catecholamine concentrations and the
pupillary reactions. At that time, it has already
been assumed that the reduced stress system’s
reactivity plays a causal role in weight gain.
In 2012, two papers have been published
almost simultaneously both confirming that
women and men with high BMI do react to
stress in a low-reactive manner (Jones et al.,
2012; Kubera et al., 2012). The two research
groups applied a mental and a psychosocial
stress test, respectively. They found blunted neu-
roendocrine, neuroenergetic, emotional, and
cardiovascular responses to stress (Table 1). As a
hallmark, both studies found a low-reactivity of
the hypothalamus-pituitary-adrenal axis in peo-
ple with high BMI (Figure 3A). One of these two
studies came from our lab and we shall report
here the results in greater details.
THE CORPULENT PHENOTYPE EXHIBITS
A ROBUST BRAIN METABOLISM DURING
STRESS
To investigate how the brain of lean or corpu-
lent humans organizes its supply and demand
during psychosocial stress, we performed the
Trier Social Stress Test in 40 men, and there-
after offered them a rich food buffet (Kubera
et al., 2012). Lean men were found high-reactive
during the stress session; they increased their
vigilance; thereby they increased their cerebral
energy need. In contrast, corpulent men were
found low reactive in this respect. Neither a
hypervigilant nor a neuroglycopenic state was
detectable in the corpulent subjects (Table 1).
Whereas the brains of normal-weight sub-
jects demanded for extra energy from the body
using CIS, CIS was not detectable in corpulent
subjects (Figure 3B) (Kubera et al., 2012). Our
findings suggest that the absence of CIS in cor-
pulent subjects was due to the absence of their
meal-related-cortisol peak. That means that in
corpulent men brain-pull function was not suf-
ficiently activated to demand for energy to pro-
cure the brain. Our results indicate that in lean
subjects, who highly activated their CIS-brain-
pull, the energy in the post-stress-replenishment
phase was rather directed toward the brain. In
contrast, the corpulent subjects, who did not
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Table 1 | Differential stress reactivity in lean and corpulent subjects.
Stress reactivity Lean subjects Corpulent subjects Evidence
(BMI 18–25) (BMI > 30)
Neuroendocrine Cortisol to acute mental stress High Low Jones et al., 2012
Cortisol to subsequent meal High Low Kubera et al., 2012
Neuroenergetic Hypervigilant state High Low Kubera et al., 2012
Cerebral insulin suppression (CIS) High Low Kubera et al., 2012
Poststress neuroglycopenic state High Low Kubera et al., 2012
Emotional Anxiety, uneasiness, physical malaise, sadness High Low Kubera et al., 2012
Cardiovascular Heart rate, blood pressure, cardiac output High Low Jones et al., 2012
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FIGURE 3 | The effect of mental stress on cortisol and CIS in lean and
corpulent humans. (A) HPA-reactivity is low in corpulent subjects: lean
subjects respond to a mental stressor in a high-reactive manner, while
corpulent subjects respond to it in a low-reactive manner (Jones et al., 2012).
(B) CIS is not detectable in corpulent subjects: glucose and insulin
concentrations are measured during stress and non-stress intervention in
corpulent and lean men. Values are means ± SEM; closed symbols, stress
intervention and open symbols, non-stress intervention. Lean men: glucose
concentrations are different from non-stress intervention (interaction time ×
stress intervention: F = 3.8, P < 0.001); insulin concentrations are equal
between stress and non-stress intervention (interaction time × stress
intervention: F = 2.5, P > 0.05), by ANOVA for repeated measures. Given
the increased glucose concentrations in the stress session, insulin is
inadequately low, i.e. suppressed (for details see Hitze et al., 2010).
Corpulent men: stress did not lead to an observable increase in glucose
concentrations (interaction × stress intervention: F = 0.6, P = 0.554) nor in
insulin concentrations in the post-stress replenishment phase (interaction
time × stress intervention: F = 0.4, P = 0.771) (Kubera et al., 2012).
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activate their CIS brain-pull, could not pre-
vent influx of energy into the peripheral energy
stores.
To assess emotional arousal during stress we
used a symptom-rating scale (Kubera et al.,
2012). The feelings of anxiety, uneasiness, physi-
cal malaise and sadness weremarkedly increased
during stress in lean men, but no such emo-
tional arousal could be observed in corpulent
men (Figure 4, Table 1).
THE “OBESITY PARADOX”—IS IT DUE TO A
CONFOUNDING FACTOR?
The association between high body mass and
high mortality risk has been cited very often.
However, the assumption that a high body mass
is really the cause of high mortality has never
been tested. This lack of evidence for a causal
relationship between the two variables “BMI”
and “mortality” is a critical issue, particularly
because of the observation that psychosocial
stress affects both body mass and mortality
(Brotman et al., 2007; Surtees et al., 2008;
Steptoe and Kivimaki, 2012). In three large-
scale studies, high cortisol concentrations have
also been shown to predict increased mortality
(Schoorlemmer et al., 2009; Vogelzangs et al.,
2010; Kumari et al., 2011). Is it possible that
chronic psychosocial stress constitutes one com-
mon cause both affecting body mass and mor-
tality? Is it conceivable that psychosocial stress
is the key factor that helps to understand the
yet unresolved obesity paradox? Recently, Peters
and McEwen made a proposal to explain the
obesity paradox by introducing stress as the
third critical confounding variable (Figure 2B)
(Peters and McEwen, 2012).
SURVIVAL ADVANTAGE IN THE CORPULENT
PHENOTYPE
For decades the BMI-mortality-curve has been
used to assess body-weight-related health risks.
A BMI of 25 kg/m2 has been considered as
optimal. Accordingly, each variation in the one
The selfish-brain-theory
Describes the characteristic of the brain
to cover its own energy requirements
with the highest priority when
regulating energy fluxes in the body.
The brain behaves selfishly in this
respect. The selfish brain theory has
been founded and formulated
mathematically between 1998 and
2004. Meanwhile, the interdisciplinary
Selfish Brain research group, supported
by the German Research Foundation,
has provided experimental evidence for
the validity of the theory’s axioms.
direction (weight loss) or in the other (weight
gain) shortens life expectancy. Graphically this
relation can be depicted as a j-shaped curve.
However, in these early statistics the distinc-
tion between type-A and type-B-stress types
could not be made, because the factor corti-
sol (allostatic load)—which in the meantime
has been shown to have an obvious impact on
mortality—has not been assessed.
If one does account for cortisol in these
analyses, then the following picture can be
seen (Figure 5A). The diagram is based on
the findings of modern mortality studies like
the EPIC-Study (Pischon et al., 2008) and
the Danish Diet, Cancer, and Health Study
(Berentzen et al., 2010). These studies do not
only rely on the BMI but also on the waist cir-
cumference to predict mortality in humans. The
diagram-position of most people in a given pop-
ulation can be found close to the j-shaped curve.
The diagram-position of individuals who dis-
play a particularly large or a particularly small
waist circumference can be found in greater
distances from the j-shaped curve.
The waist circumference is a clinical estimate
of the intra-abdominal (visceral) fat mass.
Measurements of the waist circumference
can easily be applied in large epidemiological
studies. A more exact assessment of the intra-
abdominal fat mass requires magnet resonance
imaging technique. Recent neuroendocrine
studies could show how the intra-abdominal
fat grows under the influence of cortisol (i.e.,
chronic stress). Sympathetic nerve endings
projecting to abdominal fat cells release cat-
echolamines and neuropeptide Y; cortisol
amplifies the effect of neuropeptide Y acting
on visceral fat cells and in so doing leads to
hyperplasia in these cell populations (Kuo
et al., 2007). The psychiatrist Elissa Epel has
emphasized that the waist circumference is
a good clinical marker for estimating the
allostatic load a subject has been exposed to in
the recent decades (Epel et al., 2000). Besides,
intra-abdominal fat tissue, which has grown
under the influence of cortisol, becomes an
almost autonomous organ secreting cytokines,
which may further enhance the detrimental
effects of the allostatic load. On this background
from stress research, it is possible to introduce
the confounding factor “stress” into the rela-
tionship between “BMI” and “mortality.”
In Figure 5B, those subjects who have been
exposed to high allostatic load in the recent
years find their position in the upper right
part of the diagram (red), those who had a low
allostatic load find their position in the lower
left part of the diagram (green).
How can the BMI-mortality curves be inter-
preted on the background of The Selfish Brain
Theory? Our approach distinguishes between
the reactions of the two stress types A and B
(Figure 5C):
• If type-A-individuals are moved from a safe
environment into a stressful and unsafe envi-
ronment, then their stress system remains
high-reactive in the long run, their mortal-
ity risk increases (in the diagram their posi-
tion moves upwards), and they lose body
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FIGURE 4 | Blunted emotional arousal during stress in the corpulent
phenotype. Values are means ± SEM; closed symbols, stress
intervention and open symbols, non-stress intervention. While lean
subjects showed emotional arousal in all symptoms, corpulent subjects
remained in their prevailing state of emotion. Anxiety: interaction time
× stress intervention: F = 0.373, P = 0.086 (corpulent phenotype),
F = 11.494, P = 0.003 (lean phenotype), physical malaise: interaction
time × stress intervention: F = 0.056, P = 0.815 (corpulent phenotype),
F = 5.979, P = 0.025 (lean phenotype), sadness: interaction time ×
stress intervention: F = 0.0, P = 1.00 (corpulent phenotype), F = 5.588,
P = 0.029 (lean phenotype), by ANOVA for repeated measures
(Kubera et al., 2012).
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FIGURE 5 | The BMI-mortality association is confounded by “stress.” (A) The body mass index (BMI) is not
sufficient to predict the mortality risk: modern mortality studies such as the EPIC-STUDY or the DANISH DIET,
CANCER, AND HEALTH STUDY take into account both the BMI and the waist circumference to predict the mortality
risk in humans. (B) Waist circumference and allostatic load: the size of the waist circumference can be considered as
a clinical marker for the allostatic load a person has carried over the past years. In the upper part of the diagram
(red part) the position of those subjects can be found who have carried a substantial stress burden in the past; at the
bottom (green part) the position of relaxed, unburdened subjects can be found. (C) The effect of stress on the
mortality risk in distinct phenotypes: type-A-individuals represent the left arm of the j-shaped curve, while
type-B-individuals represent the right arm.
weight (position moves to the left): These
type-A-individuals represent the left arm of
the j-shaped mortality-curve.
• If type-B-individuals are set into a stressful
and unsafe environment, their mortality risk
increases at first (position moves upwards like
in type A), but then they habituate to the
chronic stress, their stress system becomes
low-reactive thereby decreasing the allostatic
load, and in this way their mortality risk is
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lessened. However, these subjects have to eat
more to procure their brain with sufficient
energy, and thereby they gain body weight
(position moves to the lower right): these type-
B-individuals represent the right arm of the
j-shaped mortality-curve.
Thus, two distinct phenotypes may develop
under stressful conditions, a process which is
represented by a bifurcation of the mortality
curve (this bifurcation is essentially based on
the bifurcation shown in Figure 2A). It becomes
obvious that stressed corpulent people have a
lower mortality risk than stressed lean people.
REVISITING EVIDENCES FROM HUMAN
MORTALITY STUDIES
There are three classes of clinical studies: those
in which the confounding effect of “stress”
is unknown, negligibly small, or controlled.
The first class of studies is based on the BMI
only. There is no information available on
the allostatic load experienced by the partici-
pants. Thus, it cannot be excluded that stressed
corpulent people have been compared with
unstressed lean people. As a consequence of
such a mistake, inconsistent results have been
obtained within this class of studies. For exam-
ple, studies on patients with coronary artery
disease included both those reporting negative
associations between the BMI and mortality
(Gruberg et al., 2002, 2005; Gurm et al., 2002;
Powell et al., 2003; Lopez-Jimenez et al., 2004;
Eisenstein et al., 2005; Kennedy et al., 2005;
Sierra-Johnson et al., 2005; Nikolsky et al., 2006;
Mehta et al., 2007; Lavie et al., 2011) as well
as those reporting positive associations between
these two variables (Rea et al., 2001; Schwann
et al., 2001; Kaplan et al., 2002; De Bacquer et al.,
2003; Kim et al., 2003; Kuduvalli et al., 2003;
Poston et al., 2004; Rana et al., 2004; Wessel
et al., 2004; Widlansky et al., 2004; Dagenais
et al., 2005; Domanski et al., 2006; Martin
et al., 2006; Nigam et al., 2006; Benderly et al.,
2010). Such conflicts have ignited a long last-
ing debate. The uncertainty in interpreting these
inappropriate data sets is reflected by the term
“obesity paradox.”
The second class of studies is also based on
the BMI, but in these studies the confounding
effect of the allostatic load is negligibly small.
Within this class of studies there are two sub-
groups. The first subgroup of studies consists
of those, which have been carried out in crit-
ically ill patients, e.g., those who had suffered
from stroke, intracerebral hemorrhage, myocar-
dial infarction, heart failure, end-stage kidney
failure, or sepsis. It is likely that the allostatic
load was enormously high in all of these cases.
Therefore, the variance in the allostatic load
was rather small, and the confounding effect
of “stress” was negligibly. These studies con-
sistently showed negative associations between
BMI and mortality (Garrouste-Orgeas et al.,
2004; Buettner et al., 2007; Hallin et al., 2007;
Fitzgibbons et al., 2009; Kalantar-Zadeh et al.,
2010; Kim et al., 2011; Vemmos et al., 2011). The
second subgroup of studies consists of those,
which have investigated subjects from general
populations. Interestingly, when the researchers
confined their analysis to BMI-values in the
neighborhood of 25 kg/m2 (were allostatic load
is negligibly small) they also reported negative
associations between BMI and mortality (Flegal
et al., 2013).
The third class of studies controlled for the
confounding effect of “stress” by using statis-
tical means (Pischon et al., 2008; Berentzen
et al., 2010; Petursson et al., 2011; Cameron
et al., 2012; Hamer and Stamatakis, 2012). These
researchers used the BMI, but in addition they
applied the waist circumference in a multi-
variate approach. Since the waist circumfer-
ence serves as a clinical marker of the allostatic
load experienced by the participant during the
recent decades, they could statistically adjust the
BMI-mortality association for the confounding
effect of stress. These latter studies consistently
demonstrated negative associations (negative
partial regression coefficients) between BMI and
mortality.
As has been already proposed be many
researchers and clinicians, the exclusive use of
the BMI in mortality studies should be aban-
doned. Instead the multivariate approach—
making use of both the BMI and the waist
circumference—appears more appropriate.
THE ALLOSTATIC LOAD IS LOW IN THE
CORPULENT PHENOTYPE
When comparing the health risks of chron-
ically stressed type-A and type-B-individuals
we find strong evidence for several differ-
ences that are summarized in Table 2: while
A-types remain high-reactive in their stress reac-
tivity, B-types habituate and develop a low-
reactive stress system (compare also Table 1).
A-types lose body weight, but they accumu-
late visceral fat. In contrast, B-types gain body
weight, but do not accumulate much abdom-
inal fat because of the alleviated influence of
cortisol. When comparing the clinical traits,
which develop under the influence of the allo-
static load, we find that A-types display a
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Table 2 | Distinct phenotypic traits developing in stressful environments.
Developing Experimental and clinical evidence
phenotypic traits
Type A Type B
STRESS REACTIVITY
Neuroendocrine, neuroenergetic,
emotional, cardiovascular
High Low Peterson et al., 1988; Marin et al., 1992; Pasquali et al., 1993; Kirschbaum et al., 1995; Epel
et al., 2000; Jones et al., 2012; Kubera et al., 2012
CLINICAL TRAITS
High body mass − + Brunner et al., 2007; Carroll et al., 2008; Flaa et al., 2008; Jones et al., 2012; Kubera et al.,
2012; Phillips et al., 2012
Visceral fat accumulation + − Moyer et al., 1994; Epel et al., 2000; Brunner et al., 2007
Short life span + − Pischon et al., 2008; Berentzen et al., 2010; Cameron et al., 2012; Hamer and Stamatakis,
2012; Petursson et al., 2011
Infertility + − Glueck et al., 2006; De Pergola et al., 2009; Manneras-Holm et al., 2011
Arteriosclerosis + − Gianaros et al., 2009; Hamer et al., 2012; Seldenrijk et al., 2012
Arterial hypertension + − Canoy et al., 2004
Ischemic heart
disease/myocardial infarction
+ − Canoy et al., 2007; Parker et al., 2009; Schneider et al., 2010
Stroke + − Schneider et al., 2010
Typical depression + − Li et al., 2004; Vogelzangs et al., 2008; Rivenes et al., 2009; Yu et al., 2011
Suicide + − Magnusson et al., 2006; Kaplan et al., 2007; Mukamal et al., 2007, 2010; Bjerkeset et al.,
2008; Osler et al., 2008; Batty et al., 2010; Chang et al., 2012
Muscle weakness + − Hulens et al., 2001; Lafortuna et al., 2005; Maffiuletti et al., 2007; Paddon-Jones et al., 2006;
Lazzer et al., 2009
Osteoporosis/fractures + − Kim et al., 2010
Diabetes mellitus Type 2 + + Carnethon et al., 2003; Snijder et al., 2003; Parker et al., 2009
Poor mobility + Metcalf et al., 2011
Osteoarthritis + Janssen and Mark, 2006; Grotle et al., 2008; Lohmander et al., 2009; Mork et al., 2012; Wills
et al., 2012
Dark gray background indicates“health detriment”; white background indicates “health benefit”; (+) denotes a risk factor promoting the development of the clinical
trait; (−) denotes a protective factor suppressing the development of the clinical trait; (not filled) denotes lack of evidence for association.
shortened life expectancy, infertility, arterioscle-
rosis, hypertension, coronary heart disease,
myocardial infarction, stroke, typical depres-
sion, muscle atrophy, and osteoporosis. In con-
trast, B-types—although exposed to a stressful
environment—carry a markedly reduced allo-
static load because of their low-reactive stress
system. Accordingly, the clinical traits due to
allostatic load are far less developed in B-types.
Therefore, the corpulent phenotype appears to
be more stress tolerant.
Noteworthy, type 2 diabetes mellitus can
develop both in type A and type B (Carnethon
et al., 2003; Snijder et al., 2003; Parker et al.,
2009). On the one hand, an increased risk of
developing type 2 diabetes mellitus is observed
in subjects exhibiting a large waist circumfer-
ence combined with a low hip circumference—
this combination is a characteristic of type-A
phenotypes in stressful environment (Snijder
et al., 2003; Parker et al., 2009). On the other
hand, an increased risk of developing type 2
diabetes mellitus is also observed in subjects
exhibiting a low heart rate variability—which is
a characteristic of type-B phenotypes in stress-
ful environment (Carnethon et al., 2003). Some
years ago, diabetes mellitus type 2 used to be
classified by distinguishing a phenotype with
low BMI (diabetes mellitus type IIa) and from
a phenotype with high BMI (diabetes mellitus
type IIb) (Anonymus, 1997). Therefore, this for-
mer classification seems to represent the stress
types A and B. Thus, the disadvantage of devel-
oping type 2 diabetes is not restricted to one
particular stress type.
There are also costs which type B has
to pay for benefiting from the reduced allo-
static load: in order to maintain cerebral
energy homeostasis type B has to eat more.
In this way brain metabolism is balanced, i.e.,
cerebral energy concentrations are adequate,
and there is neither the need for over acti-
vating the stress system (exaggerated energy
demand) nor the need for shutting down cere-
bral function (energy sparing). But as a side
effect of this strategy, energy accumulates in
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the body periphery. The high body weight
results in osteoarthritis and impaired physical
mobility, both constituting disadvantages for
type B.
Table 2 is based on the following specific
evidences: it includes longitudinal data sets, in
which both the effect of the BMI and the effect
of the waist circumferences on a certain clini-
cal trait could be assessed. It is crucial that in
the data-analyses both the BMI and the waist
circumferences have been used as independent
variables in one multivariate statistical model.
Only if this criterion held true, then this data
set has been included in Table 2. Because the
long-term effects of stress on the respective clin-
ical traits listed cannot be disregarded, the waist
circumferences as a clinical marker of allostatic
load appears to be useful for a more profound
analysis: by controlling for the confounding
effect of stress, the waist circumference allows to
more precisely evaluate the effect of the BMI (or
the hip circumference) on a particular clinical
trait.
Two population-based studies from
Mauritius and Denmark have analyzed the
association between BMI and the mortal-
ity risk more profoundly (Berentzen et al.,
2010; Cameron et al., 2012). Specifically, the
researchers controlled for the confounding
effect of waist circumferences (marker of
allostatic load). Both studies clearly showed for
a wide range of BMI values: the higher the BMI,
the lower the mortality risk. One recent British
study even showed that corpulent subjects
(BMI > 30) without metabolic abnormalities
(lack of visceral fat accumulation, lack of hyper-
tension, elevated blood glucose or elevated
blood lipids) displayed a life expectancy that
was comparable to that of subjects with a
“normal” BMI (Hamer and Stamatakis, 2012).
Thus, when comparing type A and type B
individuals exposed to chronic stress, it turns
out that type B individuals do have the better
survival chances.
Stress also plays a crucial role in the develop-
ment of arteriosclerosis (Table 2). Data from the
Whitehall Study showed that study participants
who were high-reactive in a stress test and who
also were burdened by psychosocial stress over
the last 15 years had a dramatically increased
risk of developing coronary arteriosclerosis
(Seldenrijk et al., 2012). Those who were low-
reactive and had the same long-term stress
burden had a markedly lower risk to develop
coronary artery disease. A similar low risk was
found in those subgroups of participants who
were not exposed to psychosocial stress over the
last 15 years. Other studies confirmed the role
of stress load and stress reactivity on the devel-
opment of arteriosclerosis in cerebral vessels. In
addition, humans whose amygdala responded
in a low-reactive manner to stress stimuli had
a markedly reduced risk of developing arte-
riosclerosis in the large brain supplying arteries
(Gianaros et al., 2009).
Recent long-term studies confirm that—
when controlling for the confounding effects
of stress—high BMI is related to a lower risk
of developing arterial hypertension, myocardial
infarction and stroke (Table 2). Other studies
confirm that the risk of developing a typical
depression or the risk of committing suicide is
increased in type A (those with an increased
abdominal fat mass) while the risk is decreased
in type B (high BMI). In the corpulent phe-
notype, the depression-scores are often found
alleviated, and a change in the clinical picture
is observed. The corpulent subjects more often
present with “atypical depression,” which is not
only characterized by increased ingestive behav-
ior, but also by prolonged sleeping time. Muscle
atrophy and osteoporosis tend to rather develop
in those with a high-reactive stress system when
exposed to chronic stress. In contrast, all these
clinical traits do not develop in type B individu-
als to the same extent.
In summary, strong evidence (Table 2) sup-
ports the notion that exposure to chronic stress
results in two different phenotypes depending
on the genetic background. It turns out that
type A—which does not habituate to chronic
stress—experiences the unbuffered detrimental
effects of the allostatic load. In contrast, type
B—once exposed to a stressful environment—
habituates with his stress response and in so
doing is protected against the deleterious effects
of the allostatic load. However, this latter kind
of adaptation costs energy. The type-B-subjects
have to eat more in order to keep their brain
energy metabolism in balance. Then the surplus
of energy accumulates in the body periphery.
At the expense of weight-induced osteoarthritis
and reduced physical mobility, type B benefits
from a better overall health and longevity in
stressful environments.
CONCLUSIONS
Changing the perspective by looking upon
the brain as the final consumer in human
energy metabolism makes a striking difference:
first, it eliminates apparent conflicts that might
have occurred during interpretation of clinical
data (e.g., “obesity paradox”). Second, “obesity”
does not appear to be a disease but rather a
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phenotypic trait, which represents a success-
ful adaptation in stressful environments. A
“corpulent phenotype” can be regarded as
the result of adaptive phenotypic plasticity.
Third, efforts that aim at safely overcom-
ing corpulence should focus—as exemplarily
demonstrated (Ludwig et al., 2011, 2012)—
on how people may exit their stressful
environment.
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